Hjem › Immunsystem og lidelser › Oregon › Portland
Immunsystem og lidelser kliniske forsøg i Portland, OR
9 studier for Immunsystem og lidelser søger deltagere på steder i og omkring Portland (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
RekruttererFase 1
- Oregon Health & Science University, Portland
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RekruttererFase 3
- Oregon Health & Science University, Portland
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
RekruttererObservationsstudie
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Portland VA Medical Center, Portland
- og 1 flere
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RekruttererFase 3
- Oregon Health & Science University, Portland
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
RekruttererFase 1
- Providence Portland Medical Center, Portland
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
RekruttererFase 2
- Inmagene Site 3, Portland
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
RekruttererFase 2
- Oregon Health and Science University, Portland
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
RekruttererFase 1/2
- Providence Neurological Specialties West, Portland
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
RekruttererFase 2
- Oregon Health and Science University, Portland
Immunsystem og lidelser forsøg i andre byer
- Washington, DC13 studier
- New York City, NY12 studier
- Boston, MA10 studier
- Philadelphia, PA10 studier
- Atlanta, GA9 studier
- Houston, TX9 studier
- Cleveland, OH8 studier
- Chicago, IL8 studier
- Los Angeles, CA8 studier
- Milwaukee, WI6 studier
- Seattle, WA6 studier
- Cedar Rapids, IA6 studier
Andre studier i Portland
- Ikke-småcellet lungecancer46 studier
- Kræft (alle typer)34 studier
- Prostatakræft33 studier
- Brystkræft33 studier
- Metastatisk cancer29 studier
- Colorektal kræft28 studier
- Ægstockræft27 studier
- Lungecancer26 studier
- Akut myeloid leukæmi25 studier
- Livmoderslimhindekræft24 studier
- Pladecellekræft i hoved og hals19 studier
- Bugspytkirtelkræft19 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.